The HINT1 Knockout HT29 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT29 colorectal adenocarcinoma cell line. These cells harbor a targeted disruption of the histidine triad nucleotide-binding protein 1 (HINT1) gene, creating a loss-of-function model for studying tumor suppressor mechanisms. The polyclonal format provides a heterogeneous pool of edited alleles, enabling robust functional analysis without single-cell cloning artifacts while maintaining genetic diversity representative of the original cell line. This product is intended for researchers investigating HINT1-dependent pathways in a colorectal cancer context.
The HT29 host cell line is a well-characterized human colorectal adenocarcinoma model established from a 44-year-old Caucasian female. These epithelial cells display an adherent growth pattern and are widely used to study intestinal epithelial biology and colorectal tumorigenesis. HT29 cells harbor an APC mutation that partially activates the Wnt/??-catenin signaling pathway, making them particularly susceptible to further modulations of Wnt components. Their tumorigenic properties and well-documented genomic background render them a standard model for colorectal cancer drug screening and signaling pathway dissection.
HINT1 functions as a tumor suppressor and pro-apoptotic factor that directly binds ??-catenin and represses ??-catenin/TCF transcriptional activity. In the canonical Wnt pathway, HINT1 interacts with TCF4 and modulates the expression of downstream targets including CCND1 (cyclin D1), MYC, and AXIN2, as well as the apoptotic regulators BAX and BCL2. HINT1 activity is regulated by upstream factors such as promoter hypermethylation and is integrated within a network involving MITF, PKC, and CDK2. The pathway components encompass WNT ligands, Frizzled receptors, Dishevelled, the destruction complex (APC, Axin, GSK-3??), ??-catenin, and TCF/LEF transcription factors. HINT1 knockout eliminates this repressive control, leading to sustained ??-catenin/TCF-mediated transcription that drives proliferation and inhibits apoptosis.
In HT29 cells, loss of HINT1 exacerbates the oncogenic Wnt signaling already activated by the APC mutation, creating a model that mirrors the hyperactive ??-catenin state frequently observed in colorectal, gastric, and non-small cell lung cancers. This polyclonal knockout population is thus a valuable tool for dissecting tumor suppressor gene function in a colorectal adenocarcinoma background. It allows researchers to examine the interplay between HINT1 and core Wnt components and to assess the impact on cellular processes such as proliferation, apoptosis, and migration.
Research applications are extensive and include functional studies of Wnt/??-catenin signaling, colorectal cancer progression, and evaluation of Wnt pathway inhibitors. Representative assays compatible with these cells encompass western blotting for HINT1, ??-catenin, cyclin D1, and c-Myc; RT-qPCR analysis of Wnt target genes; TOP/FOP flash luciferase reporter assays; co-immunoprecipitation of HINT1 with ??-catenin; annexin V apoptosis detection; MTS cell proliferation assays; and migration/invasion assays. Transcriptomic profiling by RNA-seq can further elucidate global gene expression changes upon HINT1 disruption. For additional technical details or to discuss experimental design, contact Ascent Research.
